ALBANJI, M. H.; SURBAYA, S. H.; ALNAKHLI, O. A. IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION. TPM 2025, 32, 738-744.